Literature DB >> 24495226

The use of bisphosphonates in children: review of the literature and guidelines for dental management.

R N Bhatt1, S A Hibbert, C F Munns.   

Abstract

Bisphosphonates are inhibitors of osteoclastic bone resorption with therapeutic benefit in a variety of bone disorders in both adults and children. While these agents have been routinely used in adults for the past three decades, their more recent introduction into paediatric medicine means there is a paucity of data on long-term safety and effects on dental development. There is uncertainty regarding the dental management of children treated with bisphosphonates, particularly when invasive dental procedures, such as extractions and oral surgical procedures, are required. There are limited data with which to make recommendations about the dental management of patients treated with bisphosphonates, and there are no published recommendations that specifically address paediatric patients. This paper aims to outline paediatric uses and adverse effects of bisphosphonates and present recommendations on the dental management of children receiving bisphosphonates.
© 2014 Australian Dental Association.

Entities:  

Keywords:  BRONJ; Bisphosphonate; child; dental; guideline

Mesh:

Substances:

Year:  2014        PMID: 24495226     DOI: 10.1111/adj.12140

Source DB:  PubMed          Journal:  Aust Dent J        ISSN: 0045-0421            Impact factor:   2.291


  10 in total

Review 1.  Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment.

Authors:  P Trejo; F Rauch
Journal:  Osteoporos Int       Date:  2016-08-05       Impact factor: 4.507

Review 2.  Osteogenesis imperfecta: diagnosis and treatment.

Authors:  A Biggin; C F Munns
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

Review 3.  Long-Term Bisphosphonate Therapy in Osteogenesis Imperfecta.

Authors:  A Biggin; C F Munns
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

4.  Challenges of delivery of dental care and dental pathologies in children and young people with osteogenesis imperfecta.

Authors:  R Clark; C P Burren; R John
Journal:  Eur Arch Paediatr Dent       Date:  2019-03-13

5.  Computed Tomography-Based Investigation on the Effects of Intravenous Bisphosphonate Administration on Tooth Growth in a Minipig Animal Model.

Authors:  Philipp Poxleitner; Pit J Voss; David Steybe; Lisa-Marie Seibert; Stephan Zeiter; Martin J Stoddart; Rainer Schmelzeisen; Sven Otto
Journal:  Medicina (Kaunas)       Date:  2022-06-09       Impact factor: 2.948

Review 6.  The management of osteoporosis in children.

Authors:  L M Ward; V N Konji; J Ma
Journal:  Osteoporos Int       Date:  2016-04-28       Impact factor: 4.507

7.  Bisphosphonates therapy in children with Osteogenesis imperfecta: clinical experience in oral surgery.

Authors:  G Ierardo; M Bossù; G D'Angeli; M Celli; G Sfasciotti
Journal:  Oral Implantol (Rome)       Date:  2017-11-30

8.  Local vs. systemic administration of bisphosphonates in rat cleft bone graft: A comparative study.

Authors:  Christine Hong; Alison Quach; Lawrence Lin; Jeffrey Olson; Taewoo Kwon; Olga Bezouglaia; Jaime Tran; Michael Hoang; Kimberly Bui; Reuben H Kim; Sotirios Tetradis
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

Review 9.  Management of bisphosphonate preparation-treated children in the field of pediatric dentistry.

Authors:  Chieko Mitsuhata; Katsuyuki Kozai
Journal:  Jpn Dent Sci Rev       Date:  2022-04-30

10.  The assessment of surgical and non-surgical treatment of stage II medication-related osteonecrosis of the jaw.

Authors:  T Eguchi; I Kanai; A Basugi; Y Miyata; M Inoue; Y Hamada
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-11-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.